nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00448	0.00506	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00448	0.00506	CcSEcCtD
Famotidine—Pancytopenia—Bleomycin—melanoma	0.00438	0.00494	CcSEcCtD
Famotidine—Face oedema—Temozolomide—melanoma	0.00435	0.00491	CcSEcCtD
Famotidine—Anaphylactic shock—Vemurafenib—melanoma	0.00433	0.00489	CcSEcCtD
Famotidine—Infection—Vemurafenib—melanoma	0.0043	0.00486	CcSEcCtD
Famotidine—Dry skin—Temozolomide—melanoma	0.00413	0.00466	CcSEcCtD
Famotidine—Pancytopenia—Dactinomycin—melanoma	0.00409	0.00461	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00406	0.00458	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00406	0.00458	CcSEcCtD
Famotidine—Neutropenia—Dactinomycin—melanoma	0.00403	0.00454	CcSEcCtD
Famotidine—Influenza like illness—Docetaxel—melanoma	0.00401	0.00452	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00395	0.00445	CcSEcCtD
Famotidine—Haematuria—Bleomycin—melanoma	0.00392	0.00443	CcSEcCtD
Famotidine—Pancytopenia—Carmustine—melanoma	0.00383	0.00432	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00381	0.00429	CcSEcCtD
Famotidine—Neutropenia—Carmustine—melanoma	0.00377	0.00425	CcSEcCtD
Famotidine—Decreased appetite—Vemurafenib—melanoma	0.00377	0.00425	CcSEcCtD
Famotidine—Bronchitis—Temozolomide—melanoma	0.00374	0.00422	CcSEcCtD
Famotidine—Fatigue—Vemurafenib—melanoma	0.00373	0.00421	CcSEcCtD
Famotidine—Constipation—Vemurafenib—melanoma	0.0037	0.00418	CcSEcCtD
Famotidine—Pancytopenia—Temozolomide—melanoma	0.0037	0.00417	CcSEcCtD
Famotidine—Dysuria—Temozolomide—melanoma	0.00364	0.00411	CcSEcCtD
Famotidine—Neutropenia—Temozolomide—melanoma	0.00364	0.00411	CcSEcCtD
Famotidine—Upper respiratory tract infection—Temozolomide—melanoma	0.00362	0.00408	CcSEcCtD
Famotidine—Pollakiuria—Temozolomide—melanoma	0.0036	0.00406	CcSEcCtD
Famotidine—Erectile dysfunction—Temozolomide—melanoma	0.00359	0.00405	CcSEcCtD
Famotidine—Depression—Carmustine—melanoma	0.00358	0.00404	CcSEcCtD
Famotidine—Agranulocytosis—Dactinomycin—melanoma	0.00358	0.00404	CcSEcCtD
Famotidine—Photosensitivity reaction—Temozolomide—melanoma	0.00355	0.00401	CcSEcCtD
Famotidine—Depression—Temozolomide—melanoma	0.00346	0.0039	CcSEcCtD
Famotidine—Hepatitis—Dactinomycin—melanoma	0.00345	0.00389	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00344	0.00388	CcSEcCtD
Famotidine—Flushing—Bleomycin—melanoma	0.00343	0.00387	CcSEcCtD
Famotidine—Body temperature increased—Vemurafenib—melanoma	0.00342	0.00386	CcSEcCtD
Famotidine—Pharyngitis—Dactinomycin—melanoma	0.00342	0.00386	CcSEcCtD
Famotidine—Swelling—Docetaxel—melanoma	0.0034	0.00383	CcSEcCtD
Famotidine—Alopecia—Bleomycin—melanoma	0.00326	0.00368	CcSEcCtD
Famotidine—Erythema multiforme—Dactinomycin—melanoma	0.00326	0.00368	CcSEcCtD
Famotidine—Sinusitis—Temozolomide—melanoma	0.00326	0.00367	CcSEcCtD
Famotidine—Hallucination—Carmustine—melanoma	0.00321	0.00362	CcSEcCtD
Famotidine—Flushing—Dactinomycin—melanoma	0.0032	0.00361	CcSEcCtD
Famotidine—Hypersensitivity—Vemurafenib—melanoma	0.00319	0.0036	CcSEcCtD
Famotidine—Hepatitis—Temozolomide—melanoma	0.00312	0.00352	CcSEcCtD
Famotidine—Asthenia—Vemurafenib—melanoma	0.00311	0.00351	CcSEcCtD
Famotidine—Hallucination—Temozolomide—melanoma	0.0031	0.0035	CcSEcCtD
Famotidine—Pharyngitis—Temozolomide—melanoma	0.00309	0.00349	CcSEcCtD
Famotidine—Pruritus—Vemurafenib—melanoma	0.00306	0.00346	CcSEcCtD
Famotidine—Alopecia—Dactinomycin—melanoma	0.00304	0.00343	CcSEcCtD
Famotidine—Pain in extremity—Docetaxel—melanoma	0.003	0.00338	CcSEcCtD
Famotidine—Flushing—Carmustine—melanoma	0.00299	0.00338	CcSEcCtD
Famotidine—Anaemia—Bleomycin—melanoma	0.00297	0.00335	CcSEcCtD
Famotidine—Diarrhoea—Vemurafenib—melanoma	0.00296	0.00334	CcSEcCtD
Famotidine—Migraine—Docetaxel—melanoma	0.00295	0.00333	CcSEcCtD
Famotidine—Erythema multiforme—Temozolomide—melanoma	0.00295	0.00332	CcSEcCtD
Famotidine—Tinnitus—Temozolomide—melanoma	0.00291	0.00328	CcSEcCtD
Famotidine—Flushing—Temozolomide—melanoma	0.00289	0.00326	CcSEcCtD
Famotidine—Arrhythmia—Carmustine—melanoma	0.00288	0.00325	CcSEcCtD
Famotidine—Leukopenia—Bleomycin—melanoma	0.00288	0.00325	CcSEcCtD
Famotidine—Dizziness—Vemurafenib—melanoma	0.00286	0.00323	CcSEcCtD
Famotidine—Alopecia—Carmustine—melanoma	0.00285	0.00321	CcSEcCtD
Famotidine—Mental disorder—Carmustine—melanoma	0.00283	0.00319	CcSEcCtD
Famotidine—Cough—Bleomycin—melanoma	0.00281	0.00317	CcSEcCtD
Famotidine—Anaemia—Dactinomycin—melanoma	0.00277	0.00313	CcSEcCtD
Famotidine—Vomiting—Vemurafenib—melanoma	0.00275	0.00311	CcSEcCtD
Famotidine—Alopecia—Temozolomide—melanoma	0.00275	0.00311	CcSEcCtD
Famotidine—Dry skin—Docetaxel—melanoma	0.00275	0.0031	CcSEcCtD
Famotidine—Chest pain—Bleomycin—melanoma	0.00274	0.00309	CcSEcCtD
Famotidine—Myalgia—Bleomycin—melanoma	0.00274	0.00309	CcSEcCtD
Famotidine—Rash—Vemurafenib—melanoma	0.00273	0.00308	CcSEcCtD
Famotidine—Mental disorder—Temozolomide—melanoma	0.00273	0.00308	CcSEcCtD
Famotidine—Dermatitis—Vemurafenib—melanoma	0.00273	0.00308	CcSEcCtD
Famotidine—Back pain—Carmustine—melanoma	0.00272	0.00306	CcSEcCtD
Famotidine—Headache—Vemurafenib—melanoma	0.00271	0.00306	CcSEcCtD
Famotidine—Cramp muscle—Docetaxel—melanoma	0.0027	0.00304	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.0027	0.00304	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.0027	0.00304	CcSEcCtD
Famotidine—Leukopenia—Dactinomycin—melanoma	0.00268	0.00303	CcSEcCtD
Famotidine—Dysgeusia—Temozolomide—melanoma	0.00266	0.003	CcSEcCtD
Famotidine—Confusional state—Bleomycin—melanoma	0.00265	0.00299	CcSEcCtD
Famotidine—Anaphylactic shock—Bleomycin—melanoma	0.00262	0.00296	CcSEcCtD
Famotidine—Oedema—Bleomycin—melanoma	0.00262	0.00296	CcSEcCtD
Famotidine—Back pain—Temozolomide—melanoma	0.00262	0.00296	CcSEcCtD
Famotidine—Infection—Bleomycin—melanoma	0.00261	0.00294	CcSEcCtD
Famotidine—Anaemia—Carmustine—melanoma	0.00259	0.00293	CcSEcCtD
Famotidine—Agitation—Carmustine—melanoma	0.00258	0.00291	CcSEcCtD
Famotidine—Nausea—Vemurafenib—melanoma	0.00257	0.0029	CcSEcCtD
Famotidine—Thrombocytopenia—Bleomycin—melanoma	0.00257	0.0029	CcSEcCtD
Famotidine—Myalgia—Dactinomycin—melanoma	0.00255	0.00288	CcSEcCtD
Famotidine—Bronchospasm—Docetaxel—melanoma	0.00255	0.00287	CcSEcCtD
Famotidine—Leukopenia—Carmustine—melanoma	0.00251	0.00283	CcSEcCtD
Famotidine—Anaemia—Temozolomide—melanoma	0.00251	0.00283	CcSEcCtD
Famotidine—Anorexia—Bleomycin—melanoma	0.0025	0.00282	CcSEcCtD
Famotidine—Agitation—Temozolomide—melanoma	0.00249	0.00281	CcSEcCtD
Famotidine—Angioedema—Temozolomide—melanoma	0.00248	0.0028	CcSEcCtD
Famotidine—Pancytopenia—Docetaxel—melanoma	0.00246	0.00277	CcSEcCtD
Famotidine—Oedema—Dactinomycin—melanoma	0.00245	0.00276	CcSEcCtD
Famotidine—Convulsion—Carmustine—melanoma	0.00243	0.00274	CcSEcCtD
Famotidine—Infection—Dactinomycin—melanoma	0.00243	0.00274	CcSEcCtD
Famotidine—Leukopenia—Temozolomide—melanoma	0.00243	0.00274	CcSEcCtD
Famotidine—Neutropenia—Docetaxel—melanoma	0.00242	0.00273	CcSEcCtD
Famotidine—Palpitations—Temozolomide—melanoma	0.0024	0.0027	CcSEcCtD
Famotidine—Thrombocytopenia—Dactinomycin—melanoma	0.0024	0.0027	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00239	0.0027	CcSEcCtD
Famotidine—Chest pain—Carmustine—melanoma	0.00239	0.0027	CcSEcCtD
Famotidine—Myalgia—Carmustine—melanoma	0.00239	0.0027	CcSEcCtD
Famotidine—Anxiety—Carmustine—melanoma	0.00238	0.00269	CcSEcCtD
Famotidine—Cough—Temozolomide—melanoma	0.00237	0.00267	CcSEcCtD
Famotidine—Paraesthesia—Bleomycin—melanoma	0.00236	0.00266	CcSEcCtD
Famotidine—Convulsion—Temozolomide—melanoma	0.00235	0.00265	CcSEcCtD
Famotidine—Anorexia—Dactinomycin—melanoma	0.00233	0.00263	CcSEcCtD
Famotidine—Confusional state—Carmustine—melanoma	0.00231	0.00261	CcSEcCtD
Famotidine—Arthralgia—Temozolomide—melanoma	0.00231	0.00261	CcSEcCtD
Famotidine—Myalgia—Temozolomide—melanoma	0.00231	0.00261	CcSEcCtD
Famotidine—Anxiety—Temozolomide—melanoma	0.0023	0.0026	CcSEcCtD
Famotidine—Oedema—Carmustine—melanoma	0.00229	0.00258	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00229	0.00258	CcSEcCtD
Famotidine—Decreased appetite—Bleomycin—melanoma	0.00228	0.00257	CcSEcCtD
Famotidine—Infection—Carmustine—melanoma	0.00228	0.00257	CcSEcCtD
Famotidine—Dry mouth—Temozolomide—melanoma	0.00226	0.00255	CcSEcCtD
Famotidine—Jaundice—Docetaxel—melanoma	0.00225	0.00254	CcSEcCtD
Famotidine—Pain—Bleomycin—melanoma	0.00224	0.00253	CcSEcCtD
Famotidine—Thrombocytopenia—Carmustine—melanoma	0.00224	0.00253	CcSEcCtD
Famotidine—Confusional state—Temozolomide—melanoma	0.00223	0.00252	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00223	0.00252	CcSEcCtD
Famotidine—Anaphylactic shock—Temozolomide—melanoma	0.00221	0.0025	CcSEcCtD
Famotidine—Oedema—Temozolomide—melanoma	0.00221	0.0025	CcSEcCtD
Famotidine—Infection—Temozolomide—melanoma	0.0022	0.00248	CcSEcCtD
Famotidine—Anorexia—Carmustine—melanoma	0.00218	0.00246	CcSEcCtD
Famotidine—Thrombocytopenia—Temozolomide—melanoma	0.00217	0.00245	CcSEcCtD
Famotidine—Feeling abnormal—Bleomycin—melanoma	0.00216	0.00244	CcSEcCtD
Famotidine—Agranulocytosis—Docetaxel—melanoma	0.00215	0.00243	CcSEcCtD
Famotidine—Decreased appetite—Dactinomycin—melanoma	0.00213	0.0024	CcSEcCtD
Famotidine—Fatigue—Dactinomycin—melanoma	0.00211	0.00238	CcSEcCtD
Famotidine—Anorexia—Temozolomide—melanoma	0.00211	0.00238	CcSEcCtD
Famotidine—Pain—Dactinomycin—melanoma	0.00209	0.00236	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Carmustine—melanoma	0.00209	0.00235	CcSEcCtD
Famotidine—Urticaria—Bleomycin—melanoma	0.00209	0.00235	CcSEcCtD
Famotidine—Body temperature increased—Bleomycin—melanoma	0.00207	0.00234	CcSEcCtD
Famotidine—Hepatitis—Docetaxel—melanoma	0.00207	0.00234	CcSEcCtD
Famotidine—Insomnia—Carmustine—melanoma	0.00207	0.00234	CcSEcCtD
Famotidine—Paraesthesia—Carmustine—melanoma	0.00206	0.00232	CcSEcCtD
Famotidine—Pharyngitis—Docetaxel—melanoma	0.00206	0.00232	CcSEcCtD
Famotidine—Somnolence—Carmustine—melanoma	0.00204	0.0023	CcSEcCtD
Famotidine—Feeling abnormal—Dactinomycin—melanoma	0.00202	0.00228	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Temozolomide—melanoma	0.00202	0.00228	CcSEcCtD
Famotidine—Insomnia—Temozolomide—melanoma	0.002	0.00226	CcSEcCtD
Famotidine—Gastrointestinal pain—Dactinomycin—melanoma	0.002	0.00226	CcSEcCtD
Famotidine—Decreased appetite—Carmustine—melanoma	0.00199	0.00225	CcSEcCtD
Famotidine—Paraesthesia—Temozolomide—melanoma	0.00199	0.00224	CcSEcCtD
Famotidine—Somnolence—Temozolomide—melanoma	0.00197	0.00222	CcSEcCtD
Famotidine—Erythema multiforme—Docetaxel—melanoma	0.00196	0.00221	CcSEcCtD
Famotidine—Constipation—Carmustine—melanoma	0.00196	0.00221	CcSEcCtD
Famotidine—Pain—Carmustine—melanoma	0.00196	0.00221	CcSEcCtD
Famotidine—Dyspepsia—Temozolomide—melanoma	0.00195	0.0022	CcSEcCtD
Famotidine—Abdominal pain—Dactinomycin—melanoma	0.00194	0.00218	CcSEcCtD
Famotidine—Body temperature increased—Dactinomycin—melanoma	0.00194	0.00218	CcSEcCtD
Famotidine—Hypersensitivity—Bleomycin—melanoma	0.00193	0.00218	CcSEcCtD
Famotidine—Decreased appetite—Temozolomide—melanoma	0.00192	0.00217	CcSEcCtD
Famotidine—Flushing—Docetaxel—melanoma	0.00192	0.00217	CcSEcCtD
Famotidine—Fatigue—Temozolomide—melanoma	0.00191	0.00215	CcSEcCtD
Famotidine—Pain—Temozolomide—melanoma	0.00189	0.00214	CcSEcCtD
Famotidine—Constipation—Temozolomide—melanoma	0.00189	0.00214	CcSEcCtD
Famotidine—Feeling abnormal—Carmustine—melanoma	0.00189	0.00213	CcSEcCtD
Famotidine—Asthenia—Bleomycin—melanoma	0.00188	0.00212	CcSEcCtD
Famotidine—Gastrointestinal pain—Carmustine—melanoma	0.00187	0.00211	CcSEcCtD
Famotidine—Pruritus—Bleomycin—melanoma	0.00186	0.00209	CcSEcCtD
Famotidine—Arrhythmia—Docetaxel—melanoma	0.00185	0.00209	CcSEcCtD
Famotidine—Alopecia—Docetaxel—melanoma	0.00183	0.00207	CcSEcCtD
Famotidine—Feeling abnormal—Temozolomide—melanoma	0.00182	0.00206	CcSEcCtD
Famotidine—Mental disorder—Docetaxel—melanoma	0.00182	0.00205	CcSEcCtD
Famotidine—Abdominal pain—Carmustine—melanoma	0.00181	0.00204	CcSEcCtD
Famotidine—Body temperature increased—Carmustine—melanoma	0.00181	0.00204	CcSEcCtD
Famotidine—Gastrointestinal pain—Temozolomide—melanoma	0.00181	0.00204	CcSEcCtD
Famotidine—Hypersensitivity—Dactinomycin—melanoma	0.0018	0.00203	CcSEcCtD
Famotidine—Dysgeusia—Docetaxel—melanoma	0.00177	0.00199	CcSEcCtD
Famotidine—Urticaria—Temozolomide—melanoma	0.00176	0.00198	CcSEcCtD
Famotidine—Asthenia—Dactinomycin—melanoma	0.00176	0.00198	CcSEcCtD
Famotidine—Body temperature increased—Temozolomide—melanoma	0.00175	0.00197	CcSEcCtD
Famotidine—Abdominal pain—Temozolomide—melanoma	0.00175	0.00197	CcSEcCtD
Famotidine—Back pain—Docetaxel—melanoma	0.00175	0.00197	CcSEcCtD
Famotidine—Muscle spasms—Docetaxel—melanoma	0.00173	0.00196	CcSEcCtD
Famotidine—Hypersensitivity—Carmustine—melanoma	0.00169	0.0019	CcSEcCtD
Famotidine—Diarrhoea—Dactinomycin—melanoma	0.00167	0.00189	CcSEcCtD
Famotidine—Vomiting—Bleomycin—melanoma	0.00167	0.00188	CcSEcCtD
Famotidine—Anaemia—Docetaxel—melanoma	0.00167	0.00188	CcSEcCtD
Famotidine—Rash—Bleomycin—melanoma	0.00165	0.00187	CcSEcCtD
Famotidine—Dermatitis—Bleomycin—melanoma	0.00165	0.00187	CcSEcCtD
Famotidine—Asthenia—Carmustine—melanoma	0.00164	0.00185	CcSEcCtD
Famotidine—Hypersensitivity—Temozolomide—melanoma	0.00163	0.00184	CcSEcCtD
Famotidine—Syncope—Docetaxel—melanoma	0.00162	0.00183	CcSEcCtD
Famotidine—Leukopenia—Docetaxel—melanoma	0.00161	0.00182	CcSEcCtD
Famotidine—Palpitations—Docetaxel—melanoma	0.00159	0.0018	CcSEcCtD
Famotidine—Asthenia—Temozolomide—melanoma	0.00159	0.00179	CcSEcCtD
Famotidine—Loss of consciousness—Docetaxel—melanoma	0.00159	0.00179	CcSEcCtD
Famotidine—Cough—Docetaxel—melanoma	0.00157	0.00178	CcSEcCtD
Famotidine—Diarrhoea—Carmustine—melanoma	0.00157	0.00177	CcSEcCtD
Famotidine—Pruritus—Temozolomide—melanoma	0.00157	0.00177	CcSEcCtD
Famotidine—Convulsion—Docetaxel—melanoma	0.00156	0.00176	CcSEcCtD
Famotidine—Nausea—Bleomycin—melanoma	0.00156	0.00176	CcSEcCtD
Famotidine—Vomiting—Dactinomycin—melanoma	0.00156	0.00176	CcSEcCtD
Famotidine—Rash—Dactinomycin—melanoma	0.00154	0.00174	CcSEcCtD
Famotidine—Arthralgia—Docetaxel—melanoma	0.00154	0.00173	CcSEcCtD
Famotidine—Chest pain—Docetaxel—melanoma	0.00154	0.00173	CcSEcCtD
Famotidine—Myalgia—Docetaxel—melanoma	0.00154	0.00173	CcSEcCtD
Famotidine—Dizziness—Carmustine—melanoma	0.00152	0.00171	CcSEcCtD
Famotidine—Diarrhoea—Temozolomide—melanoma	0.00151	0.00171	CcSEcCtD
Famotidine—Dry mouth—Docetaxel—melanoma	0.0015	0.00169	CcSEcCtD
Famotidine—Confusional state—Docetaxel—melanoma	0.00148	0.00167	CcSEcCtD
Famotidine—Anaphylactic shock—Docetaxel—melanoma	0.00147	0.00166	CcSEcCtD
Famotidine—Oedema—Docetaxel—melanoma	0.00147	0.00166	CcSEcCtD
Famotidine—Dizziness—Temozolomide—melanoma	0.00146	0.00165	CcSEcCtD
Famotidine—Infection—Docetaxel—melanoma	0.00146	0.00165	CcSEcCtD
Famotidine—Vomiting—Carmustine—melanoma	0.00146	0.00164	CcSEcCtD
Famotidine—Nausea—Dactinomycin—melanoma	0.00145	0.00164	CcSEcCtD
Famotidine—Shock—Docetaxel—melanoma	0.00145	0.00163	CcSEcCtD
Famotidine—Rash—Carmustine—melanoma	0.00144	0.00163	CcSEcCtD
Famotidine—Dermatitis—Carmustine—melanoma	0.00144	0.00163	CcSEcCtD
Famotidine—Thrombocytopenia—Docetaxel—melanoma	0.00144	0.00163	CcSEcCtD
Famotidine—Headache—Carmustine—melanoma	0.00144	0.00162	CcSEcCtD
Famotidine—Vomiting—Temozolomide—melanoma	0.00141	0.00159	CcSEcCtD
Famotidine—Anorexia—Docetaxel—melanoma	0.0014	0.00158	CcSEcCtD
Famotidine—Rash—Temozolomide—melanoma	0.0014	0.00157	CcSEcCtD
Famotidine—Dermatitis—Temozolomide—melanoma	0.00139	0.00157	CcSEcCtD
Famotidine—Headache—Temozolomide—melanoma	0.00139	0.00156	CcSEcCtD
Famotidine—Nausea—Carmustine—melanoma	0.00136	0.00154	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Docetaxel—melanoma	0.00134	0.00151	CcSEcCtD
Famotidine—Insomnia—Docetaxel—melanoma	0.00133	0.0015	CcSEcCtD
Famotidine—Paraesthesia—Docetaxel—melanoma	0.00132	0.00149	CcSEcCtD
Famotidine—Nausea—Temozolomide—melanoma	0.00132	0.00148	CcSEcCtD
Famotidine—Somnolence—Docetaxel—melanoma	0.00131	0.00148	CcSEcCtD
Famotidine—Dyspepsia—Docetaxel—melanoma	0.0013	0.00146	CcSEcCtD
Famotidine—Decreased appetite—Docetaxel—melanoma	0.00128	0.00144	CcSEcCtD
Famotidine—Fatigue—Docetaxel—melanoma	0.00127	0.00143	CcSEcCtD
Famotidine—Pain—Docetaxel—melanoma	0.00126	0.00142	CcSEcCtD
Famotidine—Constipation—Docetaxel—melanoma	0.00126	0.00142	CcSEcCtD
Famotidine—Feeling abnormal—Docetaxel—melanoma	0.00121	0.00137	CcSEcCtD
Famotidine—Gastrointestinal pain—Docetaxel—melanoma	0.0012	0.00136	CcSEcCtD
Famotidine—Abdominal pain—Docetaxel—melanoma	0.00116	0.00131	CcSEcCtD
Famotidine—Body temperature increased—Docetaxel—melanoma	0.00116	0.00131	CcSEcCtD
Famotidine—Hypersensitivity—Docetaxel—melanoma	0.00108	0.00122	CcSEcCtD
Famotidine—Asthenia—Docetaxel—melanoma	0.00106	0.00119	CcSEcCtD
Famotidine—Pruritus—Docetaxel—melanoma	0.00104	0.00118	CcSEcCtD
Famotidine—Diarrhoea—Docetaxel—melanoma	0.00101	0.00114	CcSEcCtD
Famotidine—Dizziness—Docetaxel—melanoma	0.000974	0.0011	CcSEcCtD
Famotidine—Vomiting—Docetaxel—melanoma	0.000936	0.00106	CcSEcCtD
Famotidine—Rash—Docetaxel—melanoma	0.000928	0.00105	CcSEcCtD
Famotidine—Dermatitis—Docetaxel—melanoma	0.000927	0.00105	CcSEcCtD
Famotidine—Headache—Docetaxel—melanoma	0.000922	0.00104	CcSEcCtD
Famotidine—Nausea—Docetaxel—melanoma	0.000875	0.000987	CcSEcCtD
Famotidine—SLC22A2—Metabolism—ACER3—melanoma	0.00022	0.00194	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP17A1—melanoma	0.000219	0.00193	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—CYP17A1—melanoma	0.000216	0.00191	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PLCB4—melanoma	0.00021	0.00185	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCL1—melanoma	0.00021	0.00185	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CXCR2—melanoma	0.000204	0.0018	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—UGT2B10—melanoma	0.000201	0.00177	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—RAC2—melanoma	0.000201	0.00177	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—WNT5A—melanoma	0.000198	0.00174	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TRRAP—melanoma	0.000197	0.00174	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CUL3—melanoma	0.000197	0.00174	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKR1B10—melanoma	0.000192	0.00169	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—F2R—melanoma	0.000191	0.00168	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—ALB—melanoma	0.000189	0.00167	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HS3ST5—melanoma	0.000187	0.00165	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000187	0.00165	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—EDNRB—melanoma	0.000185	0.00163	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP1B1—melanoma	0.000185	0.00163	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—CYP1B1—melanoma	0.000182	0.0016	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—F2RL1—melanoma	0.000178	0.00157	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—ALB—melanoma	0.000175	0.00155	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—GAB2—melanoma	0.000175	0.00154	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—GNA11—melanoma	0.000175	0.00154	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—F2R—melanoma	0.000173	0.00153	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—PRKCA—melanoma	0.00017	0.0015	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—EDNRB—melanoma	0.000168	0.00148	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GRM3—melanoma	0.000168	0.00148	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000167	0.00147	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CXCR4—melanoma	0.000164	0.00145	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—BRAF—melanoma	0.000163	0.00144	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—GNAQ—melanoma	0.000162	0.00143	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KISS1—melanoma	0.000159	0.0014	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—GAB2—melanoma	0.000159	0.0014	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—GNA11—melanoma	0.000159	0.0014	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000158	0.00139	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCR1—melanoma	0.000154	0.00136	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SKI—melanoma	0.000154	0.00136	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MC1R—melanoma	0.000152	0.00134	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT3—melanoma	0.00015	0.00132	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CXCR4—melanoma	0.000149	0.00131	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—GNAQ—melanoma	0.000147	0.0013	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCR7—melanoma	0.000145	0.00128	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GRM1—melanoma	0.000145	0.00128	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ABCB1—melanoma	0.000143	0.00126	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SUFU—melanoma	0.000142	0.00125	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLCB4—melanoma	0.000142	0.00125	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.00014	0.00123	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—MDM2—melanoma	0.000137	0.0012	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT3—melanoma	0.000136	0.0012	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIP4K2A—melanoma	0.000133	0.00117	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC6A11—melanoma	0.000133	0.00117	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—BCL2L11—melanoma	0.000132	0.00117	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RHOB—melanoma	0.000132	0.00117	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000131	0.00115	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—melanoma	0.00013	0.00115	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTAP—melanoma	0.00013	0.00114	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HDAC6—melanoma	0.000127	0.00112	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—EDN1—melanoma	0.000126	0.00111	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—BRAF—melanoma	0.000125	0.0011	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ACER3—melanoma	0.000123	0.00108	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CSF2—melanoma	0.000123	0.00108	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—ALB—melanoma	0.000122	0.00108	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCR2—melanoma	0.00012	0.00106	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CXCL8—melanoma	0.00012	0.00106	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RAC2—melanoma	0.000119	0.00104	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PRKCA—melanoma	0.000118	0.00104	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—WNT5A—melanoma	0.000117	0.00103	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VEGFC—melanoma	0.000117	0.00103	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PHGDH—melanoma	0.000116	0.00102	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LUM—melanoma	0.000116	0.00102	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—EDN1—melanoma	0.000114	0.00101	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HPSE—melanoma	0.000113	0.000998	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—UGT2B10—melanoma	0.000113	0.000991	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CSF2—melanoma	0.000112	0.000984	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CUBN—melanoma	0.000111	0.000979	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000111	0.000979	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—RAC1—melanoma	0.000109	0.000963	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SDHD—melanoma	0.000107	0.000946	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—BSG—melanoma	0.000107	0.000946	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CSPG4—melanoma	0.000107	0.000946	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PRKCA—melanoma	0.000107	0.000944	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—MAP2K2—melanoma	0.000105	0.000922	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—MDM2—melanoma	0.000105	0.000922	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HS3ST5—melanoma	0.000105	0.000922	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GPAM—melanoma	0.000104	0.000916	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—F2R—melanoma	0.000102	0.000902	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—RAC1—melanoma	9.93e-05	0.000875	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EDNRB—melanoma	9.92e-05	0.000874	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ABCB1—melanoma	9.92e-05	0.000873	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PTK2B—melanoma	9.63e-05	0.000848	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GNA11—melanoma	9.37e-05	0.000825	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GAB2—melanoma	9.37e-05	0.000825	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—MAPK1—melanoma	9.34e-05	0.000823	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FLT1—melanoma	9.33e-05	0.000822	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CG—melanoma	9.24e-05	0.000814	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ALB—melanoma	8.92e-05	0.000785	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLA2G6—melanoma	8.84e-05	0.000779	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FOXO4—melanoma	8.81e-05	0.000776	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HDAC2—melanoma	8.81e-05	0.000776	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCR4—melanoma	8.81e-05	0.000776	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GNAQ—melanoma	8.71e-05	0.000767	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	8.42e-05	0.000742	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CG—melanoma	8.39e-05	0.000739	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SYK—melanoma	8.19e-05	0.000721	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CD—melanoma	8.13e-05	0.000715	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT3—melanoma	8.04e-05	0.000708	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NGFR—melanoma	8.04e-05	0.000708	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ITGAV—melanoma	8.04e-05	0.000708	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—VCAN—melanoma	7.94e-05	0.0007	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLCB4—melanoma	7.93e-05	0.000698	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	7.79e-05	0.000686	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—HRAS—melanoma	7.5e-05	0.000661	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIP4K2A—melanoma	7.46e-05	0.000657	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC6A11—melanoma	7.46e-05	0.000657	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SOCS1—melanoma	7.44e-05	0.000656	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—MAP2K1—melanoma	7.43e-05	0.000654	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—S100B—melanoma	7.43e-05	0.000654	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CD—melanoma	7.38e-05	0.00065	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTAP—melanoma	7.25e-05	0.000639	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—MAPK1—melanoma	7.16e-05	0.00063	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ERBB4—melanoma	7.1e-05	0.000625	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	7.09e-05	0.000624	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CB—melanoma	7.08e-05	0.000624	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN2B—melanoma	7.04e-05	0.00062	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CD86—melanoma	6.81e-05	0.0006	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CXCL8—melanoma	6.81e-05	0.000599	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EDN1—melanoma	6.76e-05	0.000595	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP17A1—melanoma	6.7e-05	0.00059	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CSF2—melanoma	6.6e-05	0.000581	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGF1—melanoma	6.6e-05	0.000581	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—IL2—melanoma	6.5e-05	0.000573	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PHGDH—melanoma	6.47e-05	0.000569	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LUM—melanoma	6.47e-05	0.000569	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—E2F1—melanoma	6.46e-05	0.000569	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CB—melanoma	6.43e-05	0.000566	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PDGFRA—melanoma	6.39e-05	0.000563	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HPSE—melanoma	6.34e-05	0.000558	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PRKCA—melanoma	6.33e-05	0.000557	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ITGB3—melanoma	6.33e-05	0.000557	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GNA11—melanoma	6.33e-05	0.000557	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CUBN—melanoma	6.22e-05	0.000548	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SPP1—melanoma	6.21e-05	0.000547	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ALB—melanoma	6.21e-05	0.000546	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—FASN—melanoma	6.19e-05	0.000545	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAP2K2—melanoma	6.19e-05	0.000545	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CXCL8—melanoma	6.18e-05	0.000544	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC5A5—melanoma	6.09e-05	0.000537	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—BSG—melanoma	6.01e-05	0.000529	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SDHD—melanoma	6.01e-05	0.000529	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CSPG4—melanoma	6.01e-05	0.000529	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL2—melanoma	5.91e-05	0.00052	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TERT—melanoma	5.88e-05	0.000518	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GNAQ—melanoma	5.88e-05	0.000518	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CD44—melanoma	5.88e-05	0.000518	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RAC1—melanoma	5.87e-05	0.000517	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GPAM—melanoma	5.82e-05	0.000513	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—HRAS—melanoma	5.75e-05	0.000506	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP1B1—melanoma	5.64e-05	0.000497	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HIF1A—melanoma	5.63e-05	0.000496	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KDR—melanoma	5.38e-05	0.000474	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FN1—melanoma	5.18e-05	0.000456	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOTCH1—melanoma	5.07e-05	0.000446	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CD80—melanoma	4.97e-05	0.000437	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CG—melanoma	4.96e-05	0.000437	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APC—melanoma	4.96e-05	0.000437	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KIT—melanoma	4.96e-05	0.000437	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—NRAS—melanoma	4.96e-05	0.000437	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLA2G6—melanoma	4.95e-05	0.000436	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EGF—melanoma	4.9e-05	0.000432	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—MAPK3—melanoma	4.75e-05	0.000418	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—BRAF—melanoma	4.66e-05	0.00041	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCB1—melanoma	4.65e-05	0.000409	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF1—melanoma	4.54e-05	0.0004	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—MAPK1—melanoma	4.52e-05	0.000398	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—EGFR—melanoma	4.52e-05	0.000398	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—VCAN—melanoma	4.45e-05	0.000392	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAP2K1—melanoma	4.39e-05	0.000386	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CD—melanoma	4.36e-05	0.000384	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CA—melanoma	4.32e-05	0.00038	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PRKCA—melanoma	4.28e-05	0.000377	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—KRAS—melanoma	4.27e-05	0.000376	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ERCC2—melanoma	4.24e-05	0.000373	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.21e-05	0.000371	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGF2—melanoma	4.17e-05	0.000367	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.06e-05	0.000358	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CA—melanoma	3.92e-05	0.000345	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MDM2—melanoma	3.9e-05	0.000344	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ERBB2—melanoma	3.85e-05	0.000339	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CB—melanoma	3.8e-05	0.000335	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP17A1—melanoma	3.75e-05	0.00033	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.7e-05	0.000326	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	3.65e-05	0.000322	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCL8—melanoma	3.65e-05	0.000321	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HRAS—melanoma	3.63e-05	0.000319	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN1B—melanoma	3.57e-05	0.000314	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GNA11—melanoma	3.54e-05	0.000312	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT1—melanoma	3.53e-05	0.000311	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CASP3—melanoma	3.49e-05	0.000308	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL2—melanoma	3.49e-05	0.000307	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6—melanoma	3.47e-05	0.000306	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—FASN—melanoma	3.47e-05	0.000305	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC5A5—melanoma	3.41e-05	0.0003	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCND1—melanoma	3.4e-05	0.0003	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CTNNB1—melanoma	3.37e-05	0.000297	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CG—melanoma	3.35e-05	0.000295	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP9—melanoma	3.3e-05	0.000291	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CD44—melanoma	3.29e-05	0.00029	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GNAQ—melanoma	3.29e-05	0.00029	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN1A—melanoma	3.29e-05	0.00029	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PTEN—melanoma	3.28e-05	0.000289	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NFKB1—melanoma	3.27e-05	0.000288	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARG—melanoma	3.23e-05	0.000285	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.23e-05	0.000284	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT1—melanoma	3.2e-05	0.000282	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.2e-05	0.000281	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP1B1—melanoma	3.16e-05	0.000278	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VEGFA—melanoma	2.97e-05	0.000261	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CD—melanoma	2.94e-05	0.000259	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—STAT3—melanoma	2.94e-05	0.000259	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NRAS—melanoma	2.93e-05	0.000258	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALB—melanoma	2.91e-05	0.000256	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK3—melanoma	2.81e-05	0.000247	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.79e-05	0.000245	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MYC—melanoma	2.73e-05	0.00024	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK1—melanoma	2.67e-05	0.000235	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EGFR—melanoma	2.67e-05	0.000235	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCB1—melanoma	2.6e-05	0.000229	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CB—melanoma	2.57e-05	0.000226	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS2—melanoma	2.54e-05	0.000224	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KRAS—melanoma	2.52e-05	0.000222	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PRKCA—melanoma	2.39e-05	0.000211	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ERCC2—melanoma	2.37e-05	0.000209	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CA—melanoma	2.32e-05	0.000204	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TP53—melanoma	2.24e-05	0.000197	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTEN—melanoma	2.22e-05	0.000195	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HRAS—melanoma	2.14e-05	0.000189	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6—melanoma	2.05e-05	0.000181	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.97e-05	0.000173	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT1—melanoma	1.89e-05	0.000167	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CG—melanoma	1.87e-05	0.000165	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARG—melanoma	1.81e-05	0.000159	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CD—melanoma	1.65e-05	0.000145	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALB—melanoma	1.63e-05	0.000143	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CA—melanoma	1.56e-05	0.000138	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CB—melanoma	1.44e-05	0.000126	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS2—melanoma	1.42e-05	0.000125	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKT1—melanoma	1.28e-05	0.000113	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTEN—melanoma	1.24e-05	0.000109	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CA—melanoma	8.76e-06	7.71e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKT1—melanoma	7.15e-06	6.3e-05	CbGpPWpGaD
